Schedule & Agenda

Below is the 2019 program at the BIO Investor Forum. The 2020 schedule will be updated summer 2020.

BIO Investor Forum
Date
Time
  • Show All
Company Type
  • Show All
Main Therapeutic Focus
  • Show All
Development Phase of Primary Product
  • Show All
Search Sessions
BIO Investor Forum
Jump to Day
14 Results
Tuesday, October 22
10:30 AM - 10:45 AM (EDT)
BioXcel Therapeutics is a clinical stage biopharmaceutical company focused on drug development in…
ImmunoMet is a clinical stage biotech targeting cellular metabolism to develop novel anti-tumor and…
Xoc Pharmaceuticals is an early-stage, biopharmaceutical company focused on the development of…
11:15 AM - 11:30 AM (EDT)
EnterTroy Bio is a company whose mission is to safely overcome the Blood Brain Barrier (BBB). Our …
CARMA(TM) is an mRNA-based proprietary therapeutic platform for autologous cell therapy for the…
• SHINKEI is a CNS (Central Nervous System) disorders focused pharmaceutical company using the…
2:00 PM - 2:15 PM (EDT)
Cerevance is a private pharmaceutical company focused on central nervous system diseases. The…
3:00 PM - 3:15 PM (EDT)
With a focus on alleviating human suffering and rescuing society from the ongoing opioid crisis,…
Incysus is focused on delivering a novel off-the-shelf cell therapy for the treatment of cancer. By…
3:30 PM - 3:45 PM (EDT)
Histogen is a regenerative medicine company focused on developing patented, innovative technologies…
Wednesday, October 23
9:30 AM - 9:45 AM (EDT)
VM Oncology, a clinical-stage precision oncology company, is currently developing a first-of-its…
10:00 AM - 10:15 AM (EDT)
Vigeo Therapeutics is a clinical-stage biopharmaceutical company developing novel therapeutics that…
11:00 AM - 11:15 AM (EDT)
Ilya Pharma develops next-generation biologics for treatment of wounds and skin and mucosa The…
11:15 AM - 11:30 AM (EDT)
CohBar (CWBR) is a clinical stage biotechnology company focused on the development of mitochondrial…